Oxyphenbutazone monohydrateProduct ingredient for Oxyphenbutazone
- Name
- Oxyphenbutazone monohydrate
- Drug Entry
- Oxyphenbutazone
Oxyphenbutazone was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.
- Accession Number
- DBSALT001825
- Structure
Structure for Oxyphenbutazone monohydrate (DBSALT001825)
- Synonyms
- 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione monohydrate